Journal
BLOOD
Volume 133, Issue 19, Pages 2006-2007Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2019-03-901009
Keywords
-
Categories
Ask authors/readers for more resources
Ibrutinib works, but does using it set patients up for potential relapse by causing increased genomic instability? This question is addressed in this issue of Blood by Morande et al, who provide convincing evidence that resolves a key safety issue surrounding the use of this drug, giving new insight into its mechanism of action.(1)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available